Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4017-4020

  Sweeney, Paul ^a   Karashima, Takashi ^a   Ishikura, Hisashi ^a   Wiehle, Sandy ^a   Yamashita, Motoyuki ^a   Benedict, William F ^a   Cristiano, Richard J ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCATION; POLYETHYLENEIMINE; PROTEIN P53;

ADVANCED CANCER; ANIMAL CELL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER MODEL; CELL VIABILITY; DNA VECTOR; DRUG EFFECT; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE MUTATION; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TUMOR VOLUME;

ANIMALS; DNA; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; POLYETHYLENEIMINE; TRANSDUCTION, GENETIC; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0042674293     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T., and Terada, M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52: 1393-1398, 1992.
2. Slaton, J. W., Benedict, W. F., and Dinney, C. P. p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology, 57: 852-859, 2001.
3. Nguyen, D. M., Wiehle, S. A., Roth, J. A., and Cristiano, R. J. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Ther., 4: 191-198, 1997.
4. Rieger, K. M., Little, A. F., Swart, J. M., Kastdnakis, W. V., Fitzgerald, J. M., Hess, D. T., Libertino, J. A., and Summerhayes, I. C. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br. J. Cancer, 72: 683-690, 1995.
5. Brunner, S., Furtbauer, E., Sauer, T., Kursa, M., and Wagner, E. Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine of electroporation. Mol. Ther., 5: 80-86, 2002.
6. Kuball, J., Wen, S. F., Leissner, J., Atkins, D., Meinhardt, P., Quijano, E., Engler, H., Hutchins, B., Maneval, D. C., Grace, M. J., Fritz, M. A., Storkel, S., Thuroff, J. W., Huber, C., and Schuler, M. Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. J. Clin. Oncol., 20: 957-965, 2002.
7. Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., Hong, W. K. Khuri, F. R., Kurie, J. M., Lee, J. J., Lee, J. S., Mack, M., Merritt, J. A., Nguyen, D. M., Nesbitt, J. C., Perez-Soler, R., Pisters, K. M., Putnam, J. B., Jr., Richli, W. R., Savin, M., and Waugh, M. K. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst. (Bethesda), 91: 763-771, 1999.
8. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA, 92: 7297-7301, 1995.
9. Kircheis, R., Schuller, S., Brunner, S., Ogris, M., Heider, K. H., Zauner, W., and Wagner, E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med., 1: 111-120, 1999.
10. Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rossler, V., Kursa, M., and Wagner, E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther., 8: 28-40, 2001.
11. Zou, S. M., Erbacher, P., Remy, J. S., and Behr, J. P. Systemic linear polyethylenimine (L-PE1)-mediated gene delivery in the mouse. J. Gene Med., 2: 128-134, 2000.
12. Mislick, K. A., and Baldeschwieler, J. D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA, 93: 12349-12354, 1996.
13. Ruponen, M., Yla-Herrtuala, S., and Urtti, A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta, 1415: 331-341, 1999.
14. Chollet, P., Favrot, M. C., Hurbin, A., and Coll, J. L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med., 4: 84-91, 2002.
15. Lane, D. P. Cancer. p53, guardian of the genome. Nature (Lond.) 358: 15-16, 1992.
16. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., and Frost, P. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Wash. DC), 252: 706-709, 1991.
17. Nishizaki, M., Fujiwara, T., Tanida, T., Hizuta, A., Nishimori, H., Tokino, T., Nakamura, Y., Bouvet, M., Roth, J. A., and Tanaka, N. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin. Cancer Res., 5: 1015-1023, 1999.
18. Ramesh, R., Saeki, T., Templeton, N. S., Ji, L., Stephens, L. C., Ito, I., Wilson, D. R., Wu, Z., Branch, C. D., Minna, J. D., and Roth, J. A. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol. Ther., 3: 337-350, 2001.
19. Xu, L., Pirollo, K. F., and Chang, E. H. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J. Control. Release, 74: 115-128, 2001.
20. Kay, M. A., Glorioso, J. C., and Naldini, L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med., 7: 33-40, 2001.